Federal-grade documentation for state-licensed medical cannabis operators preparing a DEA registration. The templates, SOPs, and protocols that turn “we should register” into a filing that’s actually ready to submit.
A federal expedited-registration window for state-licensed medical marijuana operations runs June 26–27, 2026. If you intend to file early, your documentation needs to be ready now — not after the window closes.
Get the DEA Readiness Platform →
Built by The Cannabis Business Advisors — licensing and compliance specialists since 2020.
The June 26–27 window, explained
State-licensed medical marijuana was placed in Schedule III of the Controlled Substances Act under a final U.S. Department of Justice order, effective April 28, 2026. That placement opened a 60-day on-ramp for affected operators to seek DEA registration on an expedited basis. The statutory 60th day falls on Saturday, June 27, 2026, which makes Friday, June 26 the practical working deadline for filing.
What the window is reported to offer operators who file within it:
- They may receive a priority response on a roughly six-month target timeline. This is an expectation, not a guarantee — the DEA has not guaranteed registration to any applicant.
- They may be permitted to continue operating during the pendency of their application, depending on their facts.
Important scope note. This window and this Schedule III placement apply only to state-licensed medical marijuana and FDA-approved products. The broader Schedule I → III rescheduling of marijuana generally is not final — it remains the subject of an administrative hearing that opens June 29, 2026.
Primary sources: U.S. Department of Justice final order; Federal Register notice 2026-08177; DEA.gov.
What’s inside the platform
- Federal documentation templates — the application-support documents formatted to federal expectations.
- Standard Operating Procedures (SOPs) — DEA-aligned SOPs covering the operational areas a registration reviewer scrutinizes.
- Diversion-prevention protocols — the controls and procedures that demonstrate product cannot leave your closed system.
- Dual-market inventory-separation workflows — procedures for keeping state-market and DEA-registered inventory cleanly separated.
- Chain-of-custody tracking — documentation models for tracking product custody end to end.
- Enhanced recordkeeping models — the elevated recordkeeping structures expected of a registrant.
Law firms tell you what the rule says. CBA hands you the documents that get you registered.
See the platform on our store →
Who it’s for
- State-licensed medical cannabis operators evaluating or actively pursuing a DEA registration.
- Operators planning to file within the June 26–27 window who need filing-ready documentation now.
- Multi-license and dual-market operators who must keep state-market and DEA-registered inventory separated and documented.
- Compliance and operations leads who would rather start from a vetted, federally-oriented template set than draft from a blank page.
Section 280E and the financial picture
For years, Section 280E of the Internal Revenue Code has denied cannabis businesses the ordinary business deductions available to other industries, because the operations involved a Schedule I substance. Schedule III placement is expected to remove these operations from Section 280E’s reach — because Section 280E applies to trades or businesses trafficking in Schedule I or II controlled substances. But whether, when, and how this affects your specific tax position depends on your entity structure, your tax year, your filings, and facts unique to your operation. This is not a settled outcome for any individual operator. Consult your tax advisor before making any decision on the basis of 280E treatment. Nothing here is tax advice.
What you can do today is get the operational and documentation side ready, so you are positioned to act on registration when your advisors confirm the path.
Frequently asked questions
What is the DEA Readiness Platform?
It is a compliance toolkit for state-licensed medical cannabis operators preparing a DEA registration. It includes federal documentation templates, Standard Operating Procedures, diversion-prevention protocols, dual-market inventory-separation workflows, chain-of-custody tracking, and enhanced recordkeeping models. It is sold through our online store.
What is the June 26–27, 2026 deadline?
State-licensed medical marijuana was placed in Schedule III by a final DOJ order effective April 28, 2026, which opened a 60-day expedited-registration window. The statutory 60th day falls on Saturday, June 27, 2026, making Friday, June 26 the practical working deadline. It is a window, not a single fixed cutoff. It is separate from the broader rescheduling hearing that opens June 29, 2026.
Is marijuana now Schedule III?
Not across the board. Only state-licensed medical marijuana and FDA-approved products were placed in Schedule III under the final order effective April 28, 2026. The broader Schedule I → III rescheduling of marijuana generally is not final and remains in an administrative hearing that opens June 29, 2026.
Does filing within the window guarantee my registration, and can I keep operating while I wait?
No. The roughly six-month priority review is a target and expectation, not a guarantee, and no applicant is guaranteed registration. Operators who file within the window may receive a response within that timeframe and may be permitted to continue operating during the pendency of their application, depending on their specific facts. Confirm what applies to your operation with qualified counsel.
Does Schedule III placement mean I no longer face Section 280E?
Schedule III placement is expected to remove these operations from Section 280E’s reach, because 280E applies to businesses trafficking in Schedule I or II substances. Whether and how that affects your specific tax position depends on facts unique to your operation, and it is not a settled outcome for any individual taxpayer. Consult your tax advisor before relying on this. This is not tax advice.
How is this different from hiring a law firm?
Law firms tell you what the rule says. The DEA Readiness Platform hands you the actual documents — the SOPs, diversion-prevention protocols, inventory-separation workflows, and recordkeeping models — built to get a state-licensed medical operator to a submittable DEA filing. Many operators use both: counsel for legal review, the platform for the documentation work.
Built by people who do this for a living
The DEA Readiness Platform comes from The Cannabis Business Advisors, a Phoenix-based cannabis consulting firm founded in 2020, working with operators nationwide on licensing preparation, operational analysis, M&A support, and exit strategy. Led by Sara Gullickson (Founder & CEO) and Maxime Kot (President).
The Cannabis Business Advisors · 1709 E Bethany Home Road, Phoenix, AZ 85016 · (602) 290-9424 · Info@TheCannabisBusinessAdvisors.com
Get the DEA Readiness Platform →
This page is general information, not legal or tax advice. Cannabis remains regulated at both federal and state levels, and your obligations depend on facts specific to your operation. Consult qualified counsel and your tax advisor before acting.